Pfizer funds real-world research on elranatamab for relapsed/refractory multiple myeloma, emphasizing safety, effectiveness, and care delivery in diverse patient populations.
MMRF Scholars Program supports early-career clinical and laboratory investigators with myeloma research funding and mentoring to advance their careers and broaden participation in the field.
2026 MGFA Registry & Real-World Data Research Funding Opportunity supports investigators using patient-reported and clinical data to improve lives affected by myasthenia gravis and related disorders.
Natera Research Grant Focused on Innovative Uses of Personalized Molecular Residual Disease Testing in Gynecologic Cancers supports researchers studying MRD-guided care to improve cancer management.
Pfizer funds research and quality improvement projects to enhance care for elderly and complex HR+/HER2- metastatic breast cancer patients in Italy, focusing on real-world, patient-centered innovations.
Grant Applications - CLL Global Research Foundation supports researchers studying CLL immunity, disease progression, and new treatments to accelerate advances in clinical care and the control and cure of CLL.